What does progression mean for Prostate Cancer and what happens next

Understanding Progression in Prostate Cancer

Progression in prostate cancer means your cancer is growing or spreading despite treatment. Let me break down what this means and what typically happens next.

What "Progression" Means

Progression is detected through several markers:

PSA (Prostate-Specific Antigen) Rising Your PSA is a blood test that measures a protein produced by the prostate. When PSA rises over time, it suggests cancer cells are multiplying. However, according to the CancerPatientLab webinar on "Liquid Biopsies," PSA can be tricky to interpret, especially in advanced prostate cancer. Sometimes PSA goes up while scans show stable disease, or vice versa—so doctors look at multiple markers together, not just PSA alone.

Imaging Changes Scans (like CT, bone scans, or PSMA-PET scans) may show:

• New tumors appearing
• Existing tumors getting larger
• Cancer spreading to new areas (metastases)

Biochemical Recurrence This is when PSA rises after initial treatment, even before you can see cancer on imaging. According to the webinars, better measures of how aggressive your cancer is include "time to biochemical recurrence (BCR)" and "PSA doubling time"—how fast your PSA is rising.

What Happens Next: Your Treatment Journey

The good news: progression doesn't mean you're out of options. Modern prostate cancer treatment has evolved dramatically, with many sequential therapies available.

The Treatment Sequence Approach

According to Dr. [removed] Armstrong's webinar "Guiding Personalized Treatment for Advanced Prostate Cancer," prostate cancer is now treated as a journey with multiple "rounds" of different therapies. Here's the general framework:

Early Progression (Hormone-Sensitive Disease) If your cancer progresses while on initial hormone therapy, your doctor typically moves to:

• Potent androgen receptor (AR) inhibitors like:
  • Enzalutamide (Xtandi)
  • Abiraterone (Zytiga)
  • Apalutamide (ARN-509)
  • Darolutamide (Nubeqa)

These drugs block testosterone more powerfully than older treatments.

Advanced Progression (Castrate-Resistant Disease) If cancer continues progressing despite hormone therapy, options include:

• Chemotherapy: Docetaxel or cabazitaxel (taxane drugs)
• Targeted therapies: PARP inhibitors (like olaparib) if you have DNA repair gene mutations (BRCA, CDK12, etc.)
• Immunotherapies: Checkpoint inhibitors and other immune-boosting treatments
• Radiopharmaceuticals: Pluvicto (lutetium-177 PSMA), which delivers radiation directly to cancer cells
• Combination approaches: Multiple drugs used together for better effect

Key Strategic Principles

According to the "Multi-omic Analysis Guides the Decisions of Brian McCloskey" webinar, doctors now use these principles when planning your next treatment:

1. Keep disease burden low - Treat aggressively early to prevent spread
2. Validate findings - Don't rely on a single test; confirm results with multiple testing methods
3. Plan ahead - Save some treatment options for future rounds as new therapies become available
4. Maintain quality of life - Balance fighting cancer with managing side effects
5. Use precision medicine - Test your tumor's specific mutations to find drugs that target YOUR cancer

Important: Monitoring During and After Treatment

Once you start a new treatment, your doctor will monitor you through:

• PSA blood tests (regularly)
• Imaging scans (periodically)
• Liquid biopsies - newer blood tests that detect circulating tumor DNA
• Clinical symptoms - how you're feeling
• Quality of life assessments

Important note from the webinars: Just because you can detect something earlier doesn't automatically mean better outcomes. Your doctor needs to ensure that detecting progression earlier actually leads to better treatment results for YOUR specific situation.

Questions to Ask Your Oncologist

When progression is detected, ask:

1. What type of progression is this? (PSA only? Imaging? How fast is it progressing?)
2. What testing do you recommend to guide my next treatment? (Genetic testing, biomarker testing, imaging?)
3. What are my treatment options in order, and why do you recommend starting with [specific option]?
4. Are there clinical trials I should consider?
5. How will we monitor whether this treatment is working? (What markers will you follow?)
6. What side effects should I expect, and how will we manage them?

The Bottom Line

Progression is a signal to change strategy, not a dead end. Modern prostate cancer treatment offers multiple sequential options, and your oncologist's job is to sequence them strategically to keep you living as long as possible with the best quality of life. Each progression may open doors to new treatment approaches—including precision medicine based on your tumor's unique biology.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.